DZDongxu Zhao

Dongxu Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dongxu Zhao has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Origin and Evolution of Protein Synthesis: A Co-Adaptation Flexible-Rigid Docking Model Based on First-Principles Reasoning

    by Dongxu Zhao, Yu Yang, Jian Sun, Jinfeng Zhang, Haotong Duan, Yuxin Tan, Laiyang Liu

    Although the "RNA World" hypothesis suggests that RNA played a crucial role in the origin of life [7], the functional framework of RNA in prebiotic protein synthesis and the mechanisms of genetic code formation during the prebiotic period remain poorly understood. Here, using the prebiotic "primordial soup" as a model, we reconstructed the detailed steps that would yield a protein with a stable ordered amino-acid sequence in the "primordial soup" at the prebiotic period. In the "primordial soup", a large number of medium- to large-sized biomolecule-like substances-such as RNA-like and protein-like molecules of various sizes and shapes, as well as related polymers like amino-acid-RNA-like etc.-did generate and accumulate. Moreover, protein-like and RNA-like molecules formed even more intricate complexes. These complexes bound free mRNA-like molecules through complementary base pairing. Subsequently, with an extremely low probability, two adjacent amino-acid-RNA-like molecules became bound to this free mRNA-like molecule, and their amino acids underwent a condensation reaction by the complexes, producing peptides and eventually proteins or polypeptides. This free mRNA-like molecule exhibits a certain flexible structure, whereas the super-large complexes formed by protein-like and RNA-like molecules (which possess certain activities) and the amino-acid-RNA molecules exhibit relatively rigid structures. Long-term evolution and mutual selection led to the emergence of proteins with stable amino acid sequences and moderate catalytic activity. In this way, the nucleotide information embedded in such mRNA-like molecules indirectly express through protein synthesis-a process we term the "A Co-Adaptation Flexible-Rigid Docking Model", where flexible mRNA-like molecules dock onto rigid complexes to enable ordered peptide formation. Finally, we show how trinucleotide codons emerge naturally from the flexible-rigid docking constraints.

  • Open Access

    Unlocking the potential of targeted protein degradation via nanoparticle-based universal strategy

    by Ti-Qiang Zhou, Weilun Sun, Zhen-Zhen Wei, Yuhua Weng, Dongxu Zhao, Mengjie Zhang, Yuanyu Huang


  • Open Access

    A Fluorescent “Turn-On” Clutch Probe for Plasma Cell-Free DNA Identification from Lung Cancer Patients

    by Lin Zhu, Dongxu Zhao, Lixin Xu, Meng Sun, Yueyue Song, Mingrui Liu, Menglin Li, Jinfeng Zhang

    Early diagnosis of cancer is of paramount significance for the therapeutic intervention of cancers. Although the detection of circulating cell-free DNA (cfDNA) has emerged as a promising, minimally invasive approach for early cancer diagnosis, there is an urgent need to develop a highly sensitive and rapid method to precisely identify plasma cfDNA from clinical samples. Herein, we report a robust fluorescent “turn-on” clutch probe based on non-emissive QDs-Ru complexes to rapidly recognize EGFR gene mutation in plasma cfDNA from lung cancer patients. In this system, the initially quenched emission of QDs is recovered while the red emission of Ru(II) complexes is switched on. This is because the Ru(II) complexes can specifically intercalate into the double-stranded DNA (dsDNA) to form Ru-dsDNA complexes and simultaneously liberate free QDs from the QDs-Ru complexes, which leads to the occurrence of an overlaid red fluorescence. In short, the fluorescent “turn-on” clutch probe offers a specific, rapid, and sensitive paradigm for the recognition of plasma cfDNA biomarkers from clinical samples, providing a convenient and low-cost approach for the early diagnosis of cancer and other gene-mutated diseases.